Cargando…

Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019–2021

OBJECTIVE: To understand community seroprevalence of SARS-CoV-2 in children and adolescents. This is vital to understanding the susceptibility of this cohort to COVID-19 and to inform public health policy for disease control such as immunisation. DESIGN: We conducted a community-based cross-sectiona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ratcliffe, Helen, Tiley, K S, Andrews, Nick, Amirthalingam, Gayatri, Vichos, I, Morey, E, Douglas, N L, Marinou, S, Plested, Emma, Aley, Parvinder, Galiza, Eva P, Faust, Saul N, Hughes, S, Murray, Clare S, Roderick, Marion, Shackley, Fiona, Oddie, Sam J, Lees, Tim, Turner, D P J, Raman, M, Owens, Stephen, Turner, Paul, Cockerill, H, Lopez Bernal, J, Linley, E, Borrow, Ray, Brown, Kevin, Ramsay, Mary Elizabeth, Voysey, M, Snape, Matthew D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887370/ https://www.ncbi.nlm.nih.gov/pubmed/35858775 http://dx.doi.org/10.1136/archdischild-2022-324375

Ejemplares similares

Nasopharyngeal Carriage of Pneumococcus in Children in England up to 10 Years After 13-Valent Pneumococcal Conjugate Vaccine Introduction: Persistence of Serotypes 3 and 19A and Emergence of 7C
por: Tiley, Karen S, et al.
Publicado: (2022)

‘Be on the TEAM’ Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents
por: Carr, Jeremy, et al.
Publicado: (2020)

Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the delta wave and vaccination
por: Oeser, Clarissa, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England
por: Vusirikala, Amoolya, et al.
Publicado: (2021)

Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial
por: Shaw, Robert H, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UK
por: Amirthalingam, Gayatri, et al.
Publicado: (2021)

Following the Omicron wave, the majority of children in England have evidence of previous COVID infection
por: Oeser, C, et al.
Publicado: (2023)

The importance of tetanus risk assessment during wound management
por: Collins, Sarah, et al.
Publicado: (2014)

Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers
por: Harris, Ross J., et al.
Publicado: (2021)

Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study – A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines
por: Shaw, Robert H., et al.
Publicado: (2023)

Irritable Bowel Syndrome Is Not Associated with an Increased Risk of Polyps and Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Vichos, Theodoros, et al.
Publicado: (2023)

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
por: Feng, Shuo, et al.
Publicado: (2021)

Antibody Persistence After Primary SARS-CoV-2 Infection and Protection Against Future Variants Including Omicron in Adolescents: National, Prospective Cohort Study
por: Aiano, Felicity, et al.
Publicado: (2023)

Pneumococcal Serotype-Specific Antibodies Persist through Early Childhood after Infant Immunization: Follow-Up from a Randomized Controlled Trial
por: Trück, Johannes, et al.
Publicado: (2014)

Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
por: Zuo, Jianmin, et al.
Publicado: (2021)

Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A Randomised Controlled Trial
por: Kelly, Eimear, et al.
Publicado: (2023)

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
por: Liu, Xinxue, et al.
Publicado: (2021)

Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial
por: Pace, David, et al.
Publicado: (2015)

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial
por: Li, Grace, et al.
Publicado: (2022)

Understanding paratyphoid infection: study protocol for the development of a human model of Salmonella enterica serovar Paratyphi A challenge in healthy adult volunteers
por: McCullagh, David, et al.
Publicado: (2015)

Rubella infection in pregnancy and congenital rubella in United Kingdom, 2003 to 2016
por: Bukasa, Antoaneta, et al.
Publicado: (2018)

Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, England
por: Ladhani, Shamez N., et al.
Publicado: (2021)

Emergence of the delta variant and risk of SARS-CoV-2 infection in secondary school students and staff: Prospective surveillance in 18 schools, England
por: Ladhani, Shamez N., et al.
Publicado: (2022)

Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021
por: Ireland, Georgina, et al.
Publicado: (2022)

Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021
por: Whitaker, Heather J, et al.
Publicado: (2021)

Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction
por: Amirthalingam, Gayatri, et al.
Publicado: (2016)

Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study
por: Amirthalingam, Gayatri, et al.
Publicado: (2017)

Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials
por: Voysey, Merryn, et al.
Publicado: (2023)

Should Pneumococcal Serotype 3 Be Included in Serotype-Specific Immunoassays?
por: Linley, Ezra, et al.
Publicado: (2019)

Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults
por: Costa Clemens, Sue Ann, et al.
Publicado: (2023)

An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females
por: Marchevsky, Natalie Gabrielle, et al.
Publicado: (2022)

Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
por: Zuo, Jianmin, et al.
Publicado: (2021)

Impact of the herpes zoster vaccination programme on hospitalised and general practice consulted herpes zoster in the 5 years after its introduction in England: a population-based study
por: Andrews, Nick, et al.
Publicado: (2020)

Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England
por: de Lusignan, Simon, et al.
Publicado: (2020)

SARS-CoV-2 infection, antibody positivity and seroconversion rates in staff and students following full reopening of secondary schools in England: A prospective cohort study, September–December 2020
por: Ladhani, Shamez N., et al.
Publicado: (2021)

SARS-CoV-2 infection and transmission in primary schools in England in June–December, 2020 (sKIDs): an active, prospective surveillance study
por: Ladhani, Shamez N, et al.
Publicado: (2021)

Epidemiology of hospitalisations due to chickenpox and quality of life lost in community and hospital settings: protocol for a prospective cohort study across two countries
por: Marlow, Robin, et al.
Publicado: (2023)

Burden of varicella complications in secondary care, England, 2004 to 2017
por: Bernal, James Lopez, et al.
Publicado: (2019)

JMM Profile: Bordetella pertussis and whooping cough (pertussis): still a significant cause of infant morbidity and mortality, but vaccine-preventable
por: Fry, Norman K., et al.
Publicado: (2021)

Impact of Extending the Timing of Maternal Pertussis Vaccination on Hospitalized Infant Pertussis in England, 2014–2018
por: Tessier, Elise, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bj1ur8jggvc2hunje4p7t5ofi1